AAAAAA

   
Results: 1-25 | 26-50 | 51-52
Results: 1-25/52
THE ROLE OF RADIOTHERAPY IN BREAST-CONSERVING TREATMENT OF DUCTAL CARCINOMA IN-SITU (DCIS) - FIRST RESULTS OF EORTC-TRIAL-10853
Authors: JULIEN J BIJKER N SYLVESTER R FENTIMAN I SALVADORI B ROUANET P AVRIL A
Citation: J. Julien et al., THE ROLE OF RADIOTHERAPY IN BREAST-CONSERVING TREATMENT OF DUCTAL CARCINOMA IN-SITU (DCIS) - FIRST RESULTS OF EORTC-TRIAL-10853, European journal of cancer, 34, 1998, pp. 20-20
ARE RISK-FACTORS FOR LOCAL AND DISTANT RECURRENCE FOLLOWING BREAST-CONSERVING THERAPY FOR EARLY BREAST-CANCER SIMILAR TO THOSE FOLLOWING MASTECTOMY
Authors: VOOGD AG NIELSEN M PETERSE JL BLICHERTTOFT M BARTELINK H VANTIENHOVEN G ANDERSEN KW SYLVESTER R VANDONGEN JA
Citation: Ag. Voogd et al., ARE RISK-FACTORS FOR LOCAL AND DISTANT RECURRENCE FOLLOWING BREAST-CONSERVING THERAPY FOR EARLY BREAST-CANCER SIMILAR TO THOSE FOLLOWING MASTECTOMY, European journal of cancer, 34, 1998, pp. 192-192
A NEW STANDARD TREATMENT FOR ADVANCED PREMENOPAUSAL BREAST-CANCER - AMETAANALYSIS OF THE COMBINED HORMONAL AGENT TRIALISTS GROUP (CHAT)
Authors: KLIJN JGM BLAMEY RW BOCCARDO F TOMINAGA T JONAT W KAUFMANN M BEEX L MAURIAC L HOCTINBOES G DUCHATEAU L SYLVESTER R
Citation: Jgm. Klijn et al., A NEW STANDARD TREATMENT FOR ADVANCED PREMENOPAUSAL BREAST-CANCER - AMETAANALYSIS OF THE COMBINED HORMONAL AGENT TRIALISTS GROUP (CHAT), European journal of cancer, 34, 1998, pp. 405-405
INTENSIVE INDUCTION-SEQUENTIAL CHEMOTHERAPY WITH BOP VIP-B COMPARED WITH TREATMENT WITH BEP/EP FOR POOR-PROGNOSIS METASTATIC NONSEMINOMATOUS GERM-CELL TUMOR - A RANDOMIZED MEDICAL-RESEARCH-COUNCIL EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER STUDY/
Authors: KAYE SB MEAD GM FOSSA S CULLEN M DEWIT R BODROGI I VANGROENINGEN C SYLVESTER R COLLETTE L STENNING S DEPRIJCK L LALLEMAND E DEMULDER P
Citation: Sb. Kaye et al., INTENSIVE INDUCTION-SEQUENTIAL CHEMOTHERAPY WITH BOP VIP-B COMPARED WITH TREATMENT WITH BEP/EP FOR POOR-PROGNOSIS METASTATIC NONSEMINOMATOUS GERM-CELL TUMOR - A RANDOMIZED MEDICAL-RESEARCH-COUNCIL EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER STUDY/, Journal of clinical oncology, 16(2), 1998, pp. 692-701
MAXIMAL ANDROGEN BLOCKADE - FINAL ANALYSIS OF EORTC PHASE-III TRIAL-30853
Authors: DENIS LJ KEUPPENS F SMITH PH WHELAN P DEMOURA JLC NEWLING D BONO A SYLVESTER R
Citation: Lj. Denis et al., MAXIMAL ANDROGEN BLOCKADE - FINAL ANALYSIS OF EORTC PHASE-III TRIAL-30853, European urology, 33(2), 1998, pp. 144-151
MAXIMUM ANDROGEN BLOCKADE USING LHRH AGONIST BUSERELIN IN COMBINATIONWITH SHORT-TERM (2 WEEKS) OR LONG-TERM (CONTINUOUS) CYPROTERONE-ACETATE IS NOT SUPERIOR TO STANDARD ANDROGEN DEPRIVATION IN THE TREATMENT OF ADVANCED PROSTATE-CANCER - FINAL ANALYSIS OF EORTC GU GROUP TRIAL-30843
Authors: DEVOOGT HJ STUDER U SCHRODER FH KLIJN JG DEPAUW M SYLVESTER R
Citation: Hj. Devoogt et al., MAXIMUM ANDROGEN BLOCKADE USING LHRH AGONIST BUSERELIN IN COMBINATIONWITH SHORT-TERM (2 WEEKS) OR LONG-TERM (CONTINUOUS) CYPROTERONE-ACETATE IS NOT SUPERIOR TO STANDARD ANDROGEN DEPRIVATION IN THE TREATMENT OF ADVANCED PROSTATE-CANCER - FINAL ANALYSIS OF EORTC GU GROUP TRIAL-30843, European urology, 33(2), 1998, pp. 152-158
AN EORTC MULTICENTER PROSPECTIVE SURVEY OF INVASIVE ASPERGILLOSIS IN HEMATOLOGICAL PATIENTS - DIAGNOSIS AND THERAPEUTIC OUTCOME
Authors: DENNING DW MARINUS A COHEN J SPENCE D HERBRECHT R PAGANO L KIBBLER C KCRMERY V OFFNER F CORDONNIER C JEHN U ELLIS M COLLETTE L SYLVESTER R
Citation: Dw. Denning et al., AN EORTC MULTICENTER PROSPECTIVE SURVEY OF INVASIVE ASPERGILLOSIS IN HEMATOLOGICAL PATIENTS - DIAGNOSIS AND THERAPEUTIC OUTCOME, The Journal of infection, 37(2), 1998, pp. 173-180
LONG-TERM FOLLOW-UP OF AN EORTC RANDOMIZED PROSPECTIVE TRIAL COMPARING INTRAVESICAL BACILLE CALMETTE-GUERIN-RIVM AND MITOMYCIN-C IN SUPERFICIAL BLADDER-CANCER
Authors: WITJES JA VANDERMEIJDEN APM COLLETTE L SYLVESTER R DEBRUYNE FMJ VANAUBEL A WITJES WPJ
Citation: Ja. Witjes et al., LONG-TERM FOLLOW-UP OF AN EORTC RANDOMIZED PROSPECTIVE TRIAL COMPARING INTRAVESICAL BACILLE CALMETTE-GUERIN-RIVM AND MITOMYCIN-C IN SUPERFICIAL BLADDER-CANCER, Urology, 52(3), 1998, pp. 403-410
EORTC PROTOCOL-30911 - PHASE-III STUDY OF INTRAVESICAL INSTILLATION OF EPIRUBICIN, BCG TICE AND BCG TICE PLUS ISONIAZID IN INTERMEDIATE ANDHIGH-RISK PTA-PTL PAPILLARY CARCINOMA OF THE BLADDER
Authors: VANDERMEIJDEN A BRAUSI M ZAMBON V KIRKELS W HOLTL W BONO A DEBALINCOURT C SYLVESTER R
Citation: A. Vandermeijden et al., EORTC PROTOCOL-30911 - PHASE-III STUDY OF INTRAVESICAL INSTILLATION OF EPIRUBICIN, BCG TICE AND BCG TICE PLUS ISONIAZID IN INTERMEDIATE ANDHIGH-RISK PTA-PTL PAPILLARY CARCINOMA OF THE BLADDER, The Journal of urology, 159(5), 1998, pp. 554-554
4 CYCLES OF BEP VS 4 CYCLES OF VIP IN PATIENTS WITH INTERMEDIATE-PROGNOSIS METASTATIC TESTICULAR NON SEMINOMA - A RANDOMIZED STUDY OF THE EORTC GENITOURINARY TRACT CANCER COOPERATIVE GROUP
Authors: DEWIT R STOTER G SLEIJFER D NEIJT JP HUININK WWT DEPRIJCK L COLLETTE L SYLVESTER R
Citation: R. Dewit et al., 4 CYCLES OF BEP VS 4 CYCLES OF VIP IN PATIENTS WITH INTERMEDIATE-PROGNOSIS METASTATIC TESTICULAR NON SEMINOMA - A RANDOMIZED STUDY OF THE EORTC GENITOURINARY TRACT CANCER COOPERATIVE GROUP, British Journal of Cancer, 78(6), 1998, pp. 828-832
SERUM ALPHA-FETOPROTEIN SURGE AFTER THE INITIATION OF CHEMOTHERAPY FOR NONSEMINOMATOUS TESTICULAR CANCER HAS AN ADVERSE PROGNOSTIC-SIGNIFICANCE
Authors: DEWIT R COLLETTE L SYLVESTER R DEMULDER PHM SLEIJFER DT HUININK WWT KAYE SB VANOOSTEROM AT BOVEN E STOTER G
Citation: R. Dewit et al., SERUM ALPHA-FETOPROTEIN SURGE AFTER THE INITIATION OF CHEMOTHERAPY FOR NONSEMINOMATOUS TESTICULAR CANCER HAS AN ADVERSE PROGNOSTIC-SIGNIFICANCE, British Journal of Cancer, 78(10), 1998, pp. 1350-1355
DOXORUBICIN VS EPIRUBICIN, REPORT OF A 2ND-LINE RANDOMIZED PHASE-II PHASE-III STUDY IN ADVANCED BREAST-CANCER/
Authors: BONTENBAL M ANDERSSON M WILDIERS J COCCONI G JASSEM J PARIDAENS R ROTMENSZ N SYLVESTER R MOURIDSEN HT KLIJN JGM VANOOSTEROM AT
Citation: M. Bontenbal et al., DOXORUBICIN VS EPIRUBICIN, REPORT OF A 2ND-LINE RANDOMIZED PHASE-II PHASE-III STUDY IN ADVANCED BREAST-CANCER/, British Journal of Cancer, 77(12), 1998, pp. 2257-2263
COMPARATIVE-STUDY OF INTRAVESICAL INSTILLATION OF EPIRUBICIN, BCG, ORBCG-RISK PTA-PT1 PAPILLARY CARCINOMA OF THE URINARY-BLADDER - FIRST RESULTS OF EORTC-30911(INH IN INTERMEDIATE AND HIGH)
Authors: VANDERMEIJDEN A BRAUSI M HOLTL W MACK D VANVELTHOVEN R DASILVA FC SYLVESTER R DEBALINCOURT C
Citation: A. Vandermeijden et al., COMPARATIVE-STUDY OF INTRAVESICAL INSTILLATION OF EPIRUBICIN, BCG, ORBCG-RISK PTA-PT1 PAPILLARY CARCINOMA OF THE URINARY-BLADDER - FIRST RESULTS OF EORTC-30911(INH IN INTERMEDIATE AND HIGH), European journal of cancer, 33, 1997, pp. 615-615
IMPORTANCE OF BLEOMYCIN IN COMBINATION CHEMOTHERAPY FOR GOOD-PROGNOSIS TESTICULAR NONSEMINOMA - A RANDOMIZED STUDY OF THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER GENITOURINARY TRACT CANCER COOPERATIVE GROUP
Authors: DEWIT R STOTER G KAYE SB SLEIJFER DT JONES WG HUININK WWT REA LA COLLETTE L SYLVESTER R
Citation: R. Dewit et al., IMPORTANCE OF BLEOMYCIN IN COMBINATION CHEMOTHERAPY FOR GOOD-PROGNOSIS TESTICULAR NONSEMINOMA - A RANDOMIZED STUDY OF THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER GENITOURINARY TRACT CANCER COOPERATIVE GROUP, Journal of clinical oncology, 15(5), 1997, pp. 1837-1843
HORMONAL-THERAPY PROLONGS SURVIVAL IN IRRADIATED LOCALLY ADVANCED BREAST-CANCER - A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER RANDOMIZED PHASE-III TRIAL
Authors: BARTELINK H RUBENS RD VANDERSCHUEREN E SYLVESTER R
Citation: H. Bartelink et al., HORMONAL-THERAPY PROLONGS SURVIVAL IN IRRADIATED LOCALLY ADVANCED BREAST-CANCER - A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER RANDOMIZED PHASE-III TRIAL, Journal of clinical oncology, 15(1), 1997, pp. 207-215
AN INTRODUCTION TO THE STATISTICAL DESIGN OF PHASE-III CANCER CLINICAL-TRIALS
Authors: SYLVESTER R
Citation: R. Sylvester, AN INTRODUCTION TO THE STATISTICAL DESIGN OF PHASE-III CANCER CLINICAL-TRIALS, European urology, 31, 1997, pp. 65-71
ADJUVANT CHEMOTHERAPY FOR LOCALIZED RESECTABLE SOFT-TISSUE SARCOMA OFADULTS - METAANALYSIS OF INDIVIDUAL DATA
Authors: TIERNEY JF STEWART LA PARMAR MKB FLETCHER CDM JONES G MOSSERI V PATEL M DEELVIRA MCR SOUHAMI RL SYLVESTER R TURSZ T ALVEGARD TA SIGURDSSON H ANTMAN K BACCHI M BAKER LH BENJAMIN RS BRADY MF BRAMWELL V BUI BN EDMONSON JH LEYVRAZ S OMURA GA ROUESSE J RYAN L VANOOSTEROM AT YANG JC
Citation: Jf. Tierney et al., ADJUVANT CHEMOTHERAPY FOR LOCALIZED RESECTABLE SOFT-TISSUE SARCOMA OFADULTS - METAANALYSIS OF INDIVIDUAL DATA, Lancet, 350(9092), 1997, pp. 1647-1654
ANALYSIS AND PRESENTATION
Authors: FRIBERG S TAUBE A SYLVESTER R OESTERLING JE
Citation: S. Friberg et al., ANALYSIS AND PRESENTATION, Urology, 49(4A), 1997, pp. 54-65
ADJUVANT CHEMOTHERAPY FOR SUPERFICIAL TRANSITIONAL-CELL BLADDER-CARCINOMA - LONG-TERM RESULTS OF A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER RANDOMIZED TRIAL COMPARING DOXORUBICIN, ETHOGLUCID AND TRANSURETHRAL RESECTION ALONE
Authors: KURTH K TUNN U AY R SCHRODER FH PAVONEMACALUSO M DEBRUYNE F TENKATE F DEPAUW M SYLVESTER R ESSED E CAUBERGH RV HOEKSTRA JW DEVOOGT HJ NEWLING DWW DEREIJKE TM MENSINK HJA GROEN JM JAKSE G LEISINGER HJ RICHARDS B ADIB RA ROBINSON M DENIS L BOUFFIOUX C SCHULMAN C CARPENTIER PJ
Citation: K. Kurth et al., ADJUVANT CHEMOTHERAPY FOR SUPERFICIAL TRANSITIONAL-CELL BLADDER-CARCINOMA - LONG-TERM RESULTS OF A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER RANDOMIZED TRIAL COMPARING DOXORUBICIN, ETHOGLUCID AND TRANSURETHRAL RESECTION ALONE, The Journal of urology, 158(2), 1997, pp. 378-384
DOES ISONIAZID REDUCE SIDE-EFFECTS OF INTRAVESICAL BACILLUS-CALMETTE-GUERIN THERAPY IN SUPERFICIAL BLADDER-CANCER - INTERIM RESULTS OF -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER PROTOCOL-30911
Authors: VEGT PDJ VANDERMEIJDEN APM SYLVESTER R BRAUSI M HOLTL W DEBALINCOURT C
Citation: Pdj. Vegt et al., DOES ISONIAZID REDUCE SIDE-EFFECTS OF INTRAVESICAL BACILLUS-CALMETTE-GUERIN THERAPY IN SUPERFICIAL BLADDER-CANCER - INTERIM RESULTS OF -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER PROTOCOL-30911, The Journal of urology, 157(4), 1997, pp. 1246-1249
DOES ISONIAZID REDUCE SIDE-EFFECTS OF INTRAVESICAL BACILLUS-CALMETTE-GUERIN THERAPY IN SUPERFICIAL BLADDER-CANCER - INTERIM RESULTS OF -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER PROTOCOL-30911 - REPLY
Authors: VEGT PDJ VANDERMEIJDEN APM SYLVESTER R BRAUSI M HOLTL W DEBALINCOURT C
Citation: Pdj. Vegt et al., DOES ISONIAZID REDUCE SIDE-EFFECTS OF INTRAVESICAL BACILLUS-CALMETTE-GUERIN THERAPY IN SUPERFICIAL BLADDER-CANCER - INTERIM RESULTS OF -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER PROTOCOL-30911 - REPLY, The Journal of urology, 157(4), 1997, pp. 1249-1249
TUMOR-MARKER CONCENTRATION AT THE START OF CHEMOTHERAPY IS A STRONGERPREDICTOR OF TREATMENT FAILURE THAN MARKER HALF-LIFE - A STUDY IN PATIENTS WITH DISSEMINATED NONSEMINOMATOUS TESTICULAR CANCER
Authors: DEWIT R SYLVESTER R TSITSA C DEMULDER PHM SLEYFER DT HUININK WWT KAYE SB VANOOSTEROM AT BOVEN E VERMEYLEN K STOTER G
Citation: R. Dewit et al., TUMOR-MARKER CONCENTRATION AT THE START OF CHEMOTHERAPY IS A STRONGERPREDICTOR OF TREATMENT FAILURE THAN MARKER HALF-LIFE - A STUDY IN PATIENTS WITH DISSEMINATED NONSEMINOMATOUS TESTICULAR CANCER, British Journal of Cancer, 75(3), 1997, pp. 432-435
CHEMORESECTION IN TA-T1 BLADDER-CANCER
Authors: BONO AV HALL RR DENIS L LOVISOLO JA SYLVESTER R HETHERINGTON J SCHROEDER FH KURTH KH MARECHAL JM BOUFFIOUX C HOEKSTRA W LANGENMEYER W RUTISHAUSER G JANKNEGT R WHELAN P CONSIDINE J
Citation: Av. Bono et al., CHEMORESECTION IN TA-T1 BLADDER-CANCER, European urology, 29(4), 1996, pp. 385-390
MARKER TUMOR RESPONSE TO THE SEQUENTIAL COMBINATION OF INTRAVESICAL THERAPY WITH MITOMYCIN-C AND BCG-RIVM IN MULTIPLE SUPERFICIAL BLADDER-TUMORS - REPORT FROM THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT ON CANCER - GENITOURINARY GROUP (EORTC-30897)
Authors: VANDERMEIJDEN APM HALL RR MACALUSO MP PAWINSKY A SYLVESTER R VANGLABBEKE M
Citation: Apm. Vandermeijden et al., MARKER TUMOR RESPONSE TO THE SEQUENTIAL COMBINATION OF INTRAVESICAL THERAPY WITH MITOMYCIN-C AND BCG-RIVM IN MULTIPLE SUPERFICIAL BLADDER-TUMORS - REPORT FROM THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT ON CANCER - GENITOURINARY GROUP (EORTC-30897), European urology, 29(2), 1996, pp. 199-203
DUST AROUND MAIN-SEQUENCE AND SUPERGIANT STARS
Authors: SYLVESTER R
Citation: R. Sylvester, DUST AROUND MAIN-SEQUENCE AND SUPERGIANT STARS, Observatory, 116(1132), 1996, pp. 206-206
Risultati: 1-25 | 26-50 | 51-52